125 related articles for article (PubMed ID: 36410088)
1. Role of social status and social environment on net survival in patients with chronic lymphocytic leukemia: A high-resolution population-based study.
Delapierre B; Troussard X; Damaj G; Dejardin O; Tron L
Cancer Epidemiol; 2023 Feb; 82():102292. PubMed ID: 36410088
[TBL] [Abstract][Full Text] [Related]
2. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
3. An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data.
International CLL-IPI working group
Lancet Oncol; 2016 Jun; 17(6):779-790. PubMed ID: 27185642
[TBL] [Abstract][Full Text] [Related]
4. Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.
Kreuzberger N; Damen JA; Trivella M; Estcourt LJ; Aldin A; Umlauff L; Vazquez-Montes MD; Wolff R; Moons KG; Monsef I; Foroutan F; Kreuzer KA; Skoetz N
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD012022. PubMed ID: 32735048
[TBL] [Abstract][Full Text] [Related]
5. Is the Social Gradient in Net Survival Observed in France the Result of Inequalities in Cancer-Specific Mortality or Inequalities in General Mortality?
Tron L; Remontet L; Fauvernier M; Rachet B; Belot A; Launay L; Merville O; Molinié F; Dejardin O; Francim Group ; Launoy G
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765616
[TBL] [Abstract][Full Text] [Related]
6. IGHV gene mutational status and 17p deletion are independent molecular predictors in a comprehensive clinical-biological prognostic model for overall survival prediction in chronic lymphocytic leukemia.
Bulian P; Rossi D; Forconi F; Del Poeta G; Bertoni F; Zucca E; Montillo M; Pozzato G; D'Arena G; Efremov DG; Marasca R; Lauria F; Gaidano G; Gattei V; Laurenti L
J Transl Med; 2012 Jan; 10():18. PubMed ID: 22289136
[TBL] [Abstract][Full Text] [Related]
7. Survival, causes of death, and the prognostic role of comorbidities in chronic lymphocytic leukemia in the pre-ibrutinib era: A population-based study.
Steingrímsson V; Lund SH; Dickman PW; Weibull CE; Björkholm M; Landgren O; Kristinsson SY
Eur J Haematol; 2022 Feb; 108(2):145-153. PubMed ID: 34714556
[TBL] [Abstract][Full Text] [Related]
8. Diabetes Mellitus Is Associated with Inferior Prognosis in Patients with Chronic Lymphocytic Leukemia: A Propensity Score-Matched Analysis.
Gao R; Man TS; Liang JH; Wang L; Zhu HY; Wu W; Fan L; Li JY; Yang T; Xu W
Cancer Res Treat; 2020 Jan; 52(1):189-206. PubMed ID: 31291713
[TBL] [Abstract][Full Text] [Related]
9. Association of advanced leukemic stage and skin cancer tumor stage with poor skin cancer outcomes in patients with chronic lymphocytic leukemia.
Velez NF; Karia PS; Vartanov AR; Davids MS; Brown JR; Schmults CD
JAMA Dermatol; 2014 Mar; 150(3):280-7. PubMed ID: 24429548
[TBL] [Abstract][Full Text] [Related]
10. Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia.
Sarfati M; Chevret S; Chastang C; Biron G; Stryckmans P; Delespesse G; Binet JL; Merle-Beral H; Bron D
Blood; 1996 Dec; 88(11):4259-64. PubMed ID: 8943862
[TBL] [Abstract][Full Text] [Related]
11. Comparison of younger versus older B-cell chronic lymphocytic leukemia patients for clinical presentation and prognosis. A retrospective study of 53 cases.
Molica S; Brugiatelli M; Callea V; Morabito F; Levato D; Nobile F; Alberti A
Eur J Haematol; 1994 Apr; 52(4):216-21. PubMed ID: 8005231
[TBL] [Abstract][Full Text] [Related]
12. mRNA overexpression of kallikrein-related peptidase 14 (KLK14) is an independent predictor of poor overall survival in chronic lymphocytic leukemia patients.
Kontos CK; Adamopoulos PG; Papageorgiou SG; Pappa V; Scorilas A
Clin Chem Lab Med; 2016 Feb; 54(2):315-24. PubMed ID: 26351937
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous malignancies in chronic lymphocytic leukemia.
Zilberg C; Ferguson AL; Lyons JG; Gupta R; Fuller SJ; Damian DL
J Dermatol; 2024 Mar; 51(3):353-364. PubMed ID: 38291978
[TBL] [Abstract][Full Text] [Related]
14. A population-based assessment of the prognostic value of the CD19 positive lymphocyte count in B-cell chronic lymphocytic leukemia using Cox and Markov models.
Cailliod R; Quantin C; Carli PM; Jooste V; Le Teuff G; Binquet C; Maynadie M
Eur J Epidemiol; 2005; 20(12):993-1001. PubMed ID: 16331430
[TBL] [Abstract][Full Text] [Related]
15. Invasive Fungal Disease in Patients with Chronic Lymphocytic Leukemia in Japan: A Retrospective Database Study.
Yasu T; Sakurai K; Akazawa M
Curr Oncol; 2022 May; 29(5):3242-3251. PubMed ID: 35621654
[TBL] [Abstract][Full Text] [Related]
16. Flow cytochemical analysis of peripheral lymphocytes in chronic B-lymphocytic leukemia. Prognostic role of the blast count determined by the H*1 system and its correlation with morphologic features.
Lanza F; Moretti S; Latorraca A; Scapoli G; Rigolin F; Castoldi G
Leuk Res; 1992; 16(6-7):639-46. PubMed ID: 1635382
[TBL] [Abstract][Full Text] [Related]
17. Circulating levels and clinical significance of soluble CD40 in patients with hematologic malignancies.
Hock BD; McKenzie JL; Patton NW; Drayson M; Taylor K; Wakeman C; Kantarjian H; Giles F; Albitar M
Cancer; 2006 May; 106(10):2148-57. PubMed ID: 16598754
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics and outcome of young chronic lymphocytic leukemia patients: a single institution study of 204 cases.
Mauro FR; Foa R; Giannarelli D; Cordone I; Crescenzi S; Pescarmona E; Sala R; Cerretti R; Mandelli F
Blood; 1999 Jul; 94(2):448-54. PubMed ID: 10397712
[TBL] [Abstract][Full Text] [Related]
19. Chronic lymphocytic leukemia in a young population.
Alshemmari SH; Hamdah A; Pandita R; Kunhikrishnan A
Leuk Res; 2021 Nov; 110():106668. PubMed ID: 34492597
[TBL] [Abstract][Full Text] [Related]
20. Comorbidities at Diagnosis, Survival, and Cause of Death in Patients with Chronic Lymphocytic Leukemia: A Population-Based Study.
Villavicencio A; Solans M; Zacarías-Pons L; Vidal A; Puigdemont M; Roncero JM; Saez M; Marcos-Gragera R
Int J Environ Res Public Health; 2021 Jan; 18(2):. PubMed ID: 33467494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]